Biotech Values

[croumagnon]

I am elated about the MEDX buyout since I am loaded on call options at $10, $11, and $12 on the basis that I considered it a prime takeover candidate for some time. However, I am surprised it did not fetch a much higher premium as in the $20s...

BMY-MEDX deal: With a 90% premium, all-cash terms, a no shop clause, and no need for financing, this deal is a fait accompli.

Perhaps but I think many shareholders may feel the same way I do and it is possible that the deal may be rejected by shareholders until BMY, or someone else, gives a higher offer. In view of that, I am wondering whether I should unload my call options tomorrow or hold on for a possible higher price...